Groundbreaking science is only as powerful as your ability to communicate it. A biotech company with genuinely novel technology and no way to explain it to investors is a company that runs out of runway before it runs out of ideas.
Luminova Biotech came to Splash Creative with exactly that problem. A New York-based biotechnology company developing cutting-edge solutions in agriculture, anti-aging, and longevity — including NSF-funded technology that harnesses light to enhance plant growth and mitochondrial function. The science was real, the funding was real, and the opportunity was real. The brand, the website, and the investor materials were not doing any of it justice.
Industry: Biotechnology / Life Sciences | Location: New York, USA | Deliverables: Branding, Web Design & Development, Deck Design
The Challenge: Translating Complex Research Into Investment Narrative
Biotech branding has a specific failure mode: it either over-explains the science (producing materials that are accurate but incomprehensible to anyone without a PhD) or under-explains it (producing materials that feel like marketing without substance). Neither works with serious investors or institutional partners.
Luminova’s existing materials were trapped in the first failure mode. Highly technical, difficult to follow without deep domain knowledge, and missing the narrative thread that turns a research program into an investment thesis. The brand, the deck, and the website all needed to work together to tell a credible, compelling story — one that respected the intelligence of the audience while making the opportunity legible to someone encountering the company for the first time.
The Approach: Science as Story, Not Science as Data
Brand Identity
The Luminova brand needed to communicate something rare in biotech: scientific authority with genuine excitement. Most life sciences brands choose authority over excitement — the result is credible but cold. Luminova’s technology is genuinely novel and the market opportunity is genuinely large. The brand had to reflect that energy without sacrificing the credibility that institutional investors require.
We built an identity around light as the central visual metaphor — fitting for a company whose core technology involves photobiomodulation. The mark, the palette, and the typographic system all express precision and dynamism simultaneously. The result is a brand that feels like it belongs in a serious scientific context while communicating momentum rather than caution.
Website Design and Development
The Luminova website was built as an investor and partner conversion tool — not a scientific publication. The architecture moves visitors through a clear narrative: the problem, the science, the application, the team, and the opportunity. Each section builds on the last, translating technical depth into strategic clarity without losing the rigor that sophisticated audiences require.
The site runs on WordPress, giving Luminova the ability to update content as the research program evolves without requiring developer involvement for every change.
Investor Deck Design
The deck was the highest-stakes deliverable — the thing that would be in front of investors when the company made its most important asks. Splash Creative designed the Luminova investor deck to do three things: communicate the science clearly, establish the team’s credibility, and make the investment thesis feel obvious rather than argued.
Dense technical content was restructured around visual hierarchy. Data was designed to communicate rather than overwhelm. The narrative arc moves from problem to technology to market to team to ask — a sequence that respects investor time and builds conviction progressively.
What This Project Demonstrates
Luminova demonstrates something Splash Creative does across biotech, life sciences, and deep tech: translating scientific complexity into strategic narrative without losing the substance that makes the science credible.
This is a distinct skill from general branding. It requires understanding both the technical content well enough to represent it accurately and the investor audience well enough to know what they need to believe and in what order. Getting that translation wrong — oversimplifying the science or failing to construct a clear thesis — costs companies that can least afford it: early-stage companies in capital-intensive categories where the next funding round is existential.
Frequently Asked Questions
Does Splash Creative work with biotech and life sciences companies?
Yes. We’ve worked with biotech companies, life sciences brands, and science-adjacent startups that need to communicate complex technical content to non-technical audiences — investors, partners, customers, and the public. The combination of strategic thinking and design execution is particularly valuable in these categories, where most agencies either have the science background or the creative skill, but rarely both.
Can Splash Creative design investor decks alongside brand and web work?
Yes — and for early-stage companies, doing the deck alongside the brand produces significantly better results than treating them as separate projects. When the brand strategy, website, and investor deck come from the same team, the narrative is consistent across every investor touchpoint. The deck reinforces the website. The website reinforces the deck. The brand makes both more credible.
How do you make highly technical content accessible without dumbing it down?
By separating the communication problem from the content problem. The science doesn’t need to be simplified — it needs to be sequenced. Investors don’t need to understand the mechanism of action in the first slide. They need to understand the problem, believe the opportunity is real, and trust that the team can execute. The technical depth comes in when it’s needed, after the narrative has created the context for it to land.
If you’re a biotech or life sciences company that needs materials that can actually raise money, let’s talk.
